TCG Crossover GP II LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
TCG Crossover GP II LLC
CIK #0001969280
EDGAR Form CIK 2011 - 2026
3 [0001969280]
4 [0001969280]
SC 13G [0001969280]
Form 13D/13G Filer Form 13D/13G Subject Filed
TCG Crossover GP II LLC Zai Lab Ltd [2026-06-11]
TCG Crossover GP II LLC AURA Biosciences Inc [2026-05-12]
TCG Crossover GP II LLC Avalo Therapeutics Inc [2026-05-12]
TCG Crossover GP II LLC Altimmune Inc [2026-05-01]
TCG Crossover GP II LLC Vor Biopharma Inc [2026-04-01]
TCG Crossover GP II LLC Tectonic Therapeutic Inc [2026-02-27]
TCG Crossover GP II LLC ADC Therapeutics Sa [2026-02-17]
TCG Crossover GP II LLC ALX Oncology Holdings Inc [2026-02-06]
TCG Crossover GP II LLC Perspective Therapeutics Inc [2026-02-06]
TCG Crossover GP II LLC Surrozen Inc/DE [2026-02-02]
TCG Crossover GP II LLC Century Therapeutics Inc [2026-01-15]
TCG Crossover GP II LLC Alector Inc [2025-11-14]
TCG Crossover GP II LLC Monte Rosa Therapeutics Inc [2025-10-17]
TCG Crossover GP II LLC RAPT Therapeutics Inc [2025-01-03]
TCG Crossover GP II LLC Cidara Therapeutics Inc [2024-12-03]
TCG Crossover GP II LLC Dianthus Therapeutics Inc /DE/ [2024-11-22]
TCG Crossover GP II LLC Tango Therapeutics Inc [2024-11-20]
TCG Crossover GP II LLC Eyepoint Pharmaceuticals Inc [2024-11-07]
TCG Crossover GP II LLC Third Harmonic Bio Inc [2024-09-27]
TCG Crossover GP II LLC Fulcrum Therapeutics Inc [2024-09-20]
TCG Crossover GP II LLC Amylyx Pharmaceuticals Inc [2024-08-26]
TCG Crossover GP II LLC Nektar Therapeutics [2024-03-15]
TCG Crossover GP II LLC Adverum Biotechnologies Inc [2024-02-15]
TCG Crossover GP II LLC Mineralys Therapeutics Inc [2024-02-15]
TCG Crossover GP II LLC Astria Therapeutics Inc [2024-01-16]
TCG Crossover GP II LLC Vistagen Therapeutics Inc [2023-10-16]
Form 3/4/5 Subject 2011 - 2026
TCG Crossover Fund II LP
TCG Crossover Fund III LP
TCG Crossover GP III LLC
TCG Crossover GP II LLC
Vor Biopharma Inc
Surrozen Inc/DE
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Surrozen Inc/DE SRZN
Common Stock
2026-03-24 Buy 53,329 $24.69 1,316,693
Surrozen Inc/DE SRZN
Common Stock
2026-03-24 Buy 53,329 $24.69 1,316,693
Surrozen Inc/DE SRZN
Common Stock
2026-03-23 Buy 7,612 $24.90 189,539
Surrozen Inc/DE SRZN
Common Stock
2026-03-23 Buy 7,611 $24.90 189,514
Surrozen Inc/DE SRZN
Common Stock
2026-03-16 Buy 595 $24.99 14,869
Surrozen Inc/DE SRZN
Common Stock
2026-03-16 Buy 595 $24.99 14,869
Surrozen Inc/DE SRZN
Common Stock
2026-03-13 Buy 17,717 $24.88 440,799
Surrozen Inc/DE SRZN
Common Stock
2026-03-13 Buy 17,716 $24.88 440,774
Surrozen Inc/DE SRZN
Common Stock
2026-03-12 Buy 6,187 $24.99 154,613
Surrozen Inc/DE SRZN
Common Stock
2026-03-12 Buy 6,187 $24.99 154,613
Surrozen Inc/DE SRZN
Common Stock
2026-02-12 Buy 547 $23.86 13,051
Surrozen Inc/DE SRZN
Common Stock
2026-02-12 Buy 546 $23.86 13,028
Surrozen Inc/DE SRZN
Common Stock
2026-02-11 Buy 8,881 $23.58 209,414
Surrozen Inc/DE SRZN
Common Stock
2026-02-11 Buy 8,882 $23.58 209,438
Surrozen Inc/DE SRZN
Common Stock
2026-02-03 Buy 2,177 $21.94 47,763
Surrozen Inc/DE SRZN
Common Stock
2026-02-03 Buy 2,178 $21.94 47,785
Surrozen Inc/DE SRZN
Common Stock
2026-02-02 Buy 366 $21.38 7,825
Surrozen Inc/DE SRZN
Common Stock
2026-02-02 Buy 365 $21.38 7,804
Surrozen Inc/DE SRZN
Common Stock
2026-01-30 Buy 2,135 $21.39 45,668
Surrozen Inc/DE SRZN
Common Stock
2026-01-30 Buy 2,136 $21.39 45,689
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com